Literature DB >> 18180095

Suppression of tumor-induced angiogenesis by taspine isolated from Radix et Rhizoma Leonticis and its mechanism of action in vitro.

Yanmin Zhang1, Langchong He, Liang Meng, Wenjuan Luo, Xuemei Xu.   

Abstract

The present study was to demonstrate the effect of taspine isolated from Radix et Rhizoma Leonticis on tumor angiogenesis and its mechanism of action. The anti-angiogenic effect in vivo was evaluated on chicken chorioallantoic membrane (CAM) neovascularisation model and CAM transplantation tumor model. Taspine exerted inhibitory influence on CAM angiogenesis and the growth and microvessel density (MVD) of CAM transplantation tumor at concentrations of 0.5-2μg/egg. The mechanism was demonstrated through detecting vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) protein secretion by enzyme-linked immunosorbent assay (ELISA), as well as mRNA expression of VEGF, Flt-1 and Flk-1/KDR by reverse transcription-polymerase chain reaction (RT-PCR). The results showed that taspine down-regulated the VEGF and bFGF secretion in human non-small cell lung cancer cell (A549 cell) and human umbilical vein endothelial cell (HUVEC), and the VEGF and Flk-1/KDR mRNA expression in HUVEC. Additionally, the effect of taspine on HUVEC migration was detected with the method of cell scrape. The result indicated that taspine inhibited HUVEC migration in a dose-dependent manner. These findings suggest that taspine might be a promising candidate as angiogenesis inhibitors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18180095     DOI: 10.1016/j.canlet.2007.11.035

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  9 in total

1.  A novel angiogenesis inhibitor impairs lovo cell survival via targeting against human VEGFR and its signaling pathway of phosphorylation.

Authors:  Y M Zhang; B L Dai; L Zheng; Y Z Zhan; J Zhang; W W Smith; X L Wang; Y N Chen; L C He
Journal:  Cell Death Dis       Date:  2012-10-11       Impact factor: 8.469

Review 2.  The Chick Embryo Chorioallantoic Membrane as an In Vivo Assay to Study Antiangiogenesis.

Authors:  Domenico Ribatti
Journal:  Pharmaceuticals (Basel)       Date:  2010-03-08

3.  Brucine suppresses colon cancer cells growth via mediating KDR signalling pathway.

Authors:  Wenjuan Luo; Xiaoli Wang; Lei Zheng; Yingzhuan Zhan; Dongdong Zhang; Jie Zhang; Yanmin Zhang
Journal:  J Cell Mol Med       Date:  2013-08-02       Impact factor: 5.310

Review 4.  Antiangiogenic Effect of Alkaloids.

Authors:  Masoud Alasvand; Vahideh Assadollahi; Roberto Ambra; Ehsan Hedayati; Wesam Kooti; Ilaria Peluso
Journal:  Oxid Med Cell Longev       Date:  2019-04-21       Impact factor: 6.543

5.  Identification of a novel topoisomerase inhibitor effective in cells overexpressing drug efflux transporters.

Authors:  Walid Fayad; Mårten Fryknäs; Slavica Brnjic; Maria Hägg Olofsson; Rolf Larsson; Stig Linder
Journal:  PLoS One       Date:  2009-10-02       Impact factor: 3.240

6.  A novel taspine derivative suppresses human liver tumor growth and invasion in vitro and in vivo.

Authors:  Nan Wang; Lei Zheng; Yingzhuan Zhan; Yanmin Zhang
Journal:  Oncol Lett       Date:  2013-07-09       Impact factor: 2.967

7.  Chinese medicinal formula Guanxin Shutong capsule protects the heart against oxidative stress and apoptosis induced by ischemic myocardial injury in rats.

Authors:  Yanjun Cao; Xu He; Feng Lui; Zhuangzhuang Huang; Yanmin Zhang
Journal:  Exp Ther Med       Date:  2014-02-13       Impact factor: 2.447

8.  A novel tissue model for angiogenesis: evaluation of inhibitors or promoters in tissue level.

Authors:  Bingling Dai; Yanmin Zhang; Yingzhuan Zhan; Dongdong Zhang; Nan Wang; Langchong He
Journal:  Sci Rep       Date:  2014-01-15       Impact factor: 4.379

Review 9.  Genus caulophyllum: an overview of chemistry and bioactivity.

Authors:  Yong-Gang Xia; Guo-Yu Li; Jun Liang; Bing-You Yang; Shao-Wa Lü; Hai-Xue Kuang
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-04       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.